Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603579'
s EV-to-FCF Range Over the Past 10 Years
Min: -52.05 Med: 29.83 Max: 286.73
Current: 46.48
During the past 13 years, the highest EV-to-FCF of Shanghai Rongtai Health Technology was 286.73. The lowest was -52.05. And the median was 29.83.
SHSE:603579's EV-to-FCF is ranked worse than 80.84% of 569
companies
in the Travel & Leisure industry
Industry Median: 15.33
vs SHSE:603579: 46.48
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Rongtai Health Technology (SHSE:603579) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Shanghai Rongtai Health Technology's PE Ratio (TTM) for today is calculated as:
Shanghai Rongtai Health Technology's share price for today is ¥16.30.
Shanghai Rongtai Health Technology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.930.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Shanghai Rongtai Health Technology EV-to-FCF Related Terms
Shanghai Rongtai Health Technology EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology EV-to-FCF Chart
For the Leisure subindustry, Shanghai Rongtai Health Technology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology EV-to-FCF vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's EV-to-FCF falls into.
Shanghai Rongtai Health Technology's current Enterprise Value is ¥2,369 Mil.
Shanghai Rongtai Health Technology's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Rongtai Health Technology (SHSE:603579) has a EV-to-FCF of 46.48 as of Jul. 25, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 56% above median its historical median of 29.83. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #460 out of 569 companies in the Travel & Leisure industry, placing it in the top 80.8%.
Is Shanghai Rongtai Health Technology's EV-to-FCF too high?
Shanghai Rongtai Health Technology's current EV-to-FCF of 46.48 is 56% above median its 10-year median of 29.83. The Travel & Leisure industry median EV-to-FCF is 15.33. Shanghai Rongtai Health Technology's value of 46.48 is 203.2% above this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #460 out of 569 companies in the Travel & Leisure industry, which is in the bottom quartile relative to peers. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's EV-to-FCF compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #460 out of 569 companies for EV-to-FCF. This places Shanghai Rongtai Health Technology in the lower half of its industry. The industry median EV-to-FCF is 15.33. Shanghai Rongtai Health Technology's value of 46.48 is 203.2% above this benchmark. While the company's 10-year median is 29.83 vs. the industry median of 15.33, Shanghai Rongtai Health Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Travel & Leisure company?
The median EV-to-FCF among Travel & Leisure companies is 15.33, based on 569 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current EV-to-FCF of 46.48 is 203.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median EV-to-FCF is 15.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current EV-to-FCF is 46.48, which is 56% above median its own 10-year median of 29.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.92, compared to a current price of ¥16.30 — trading 2.4% above its estimated fair value. The current EV-to-FCF is 46.48, which is 56% above median its 10-year median of 29.83 and 203.2% above the Travel & Leisure industry median of 15.33. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current EV-to-FCF is 46.48 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥16.30 is trading 2.4% above its estimated GF Value™ of ¥15.92.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
EV-to-FCF: 46.48 (56% above median its 10-year median of 29.83)
GF Value™: ¥15.92 vs. price of ¥16.30 (2.4% above fair value)
Industry Position: 203.2% above the Travel & Leisure median (#460 of 569)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Business Description
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
